Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                News & Events

News & Events

                        


                        FDA Meetings, Conferences and Workshops
          OTP Events, Meetings, and Workshops
          Rumor Control
          Approvals of FDA-Regulated Products
          Congressional Testimony
          FDA Newsroom
          Interactive and Social Media
          Public Health Focus
          Speeches by FDA Officials Home
          News & Events
          FDA Office of Clinical Pharmacology and International Society of Pharmacometrics (ISoP) Public Workshop: Using Modeling and Simulation to Select Dosages for Combination Therapies and New Indications - 11/09/2023News & Events Workshop
    Event Title
              FDA Office of Clinical Pharmacology and International Society of Pharmacometrics (ISoP) Public Workshop: Using Modeling and Simulation to Select Dosages for Combination Therapies and New Indications


                  November 9, 2023

  

    
  Share
    Post
    Linkedin

    Email
    PrintOn This Page
      Meeting InformationDate:
          
  


     
           

November 9, 2023   

 
 
        
                                      Time: 
                                      
8:00 AM
    - 4:45 PM
ET

 

  About

The meeting will be held as a hybrid event, hosted from the Gaylord National Resort and Convention Center in National Harbor, Maryland, on November 9, 2023, 8:00am-4:45pm.

Goals and Objectives:

To discuss best practices and methods to incorporate quantitative methods into the clinical development of oncologic products as a means to support dosage optimization that has been strongly advocated for in recent engagements.
	To describe the impact of dosage exploration on the benefit/risk assessment for oncologic drugs and highlight ongoing efforts from regulatory agencies, academic centers, and industry to shift current practices used to select dosages for investigation in clinical trials and identify the recommended dosage for marketing applications and labeling.
	To discuss development of investigational and approved drugs in new combination or disease setting using model-based approaches to select, support and investigate dosing regimen(s).Who Should Attend:

This workshop is intended for interested parties regarding ongoing efforts; parties interested in continued advocacy for alternatives to traditional dose finding for oncologic drugs. The primary audience includes, clinical pharmacologists, pharmacometricians, pharmacologists/toxicologists, clinicians/healthcare providers, statisticians, patients, and patient advocates.

Registration:

Visit the ISOP website to register.

Agenda and Presenter Bios

View workshop agenda and bios**Contact**:

**If to ISoP:**

Jennifer Pastore Monroy, CAE
Executive Director, International Society of Pharmacometrics jennifer.monroy@go-isop.org
Bridgewater, NJ 08807

**If to FDA:**

Bernadette Johnson-Williams, DHSc, MEd
Office of Clinical Pharmacology/OTS/CDER
Silver Spring, MD 21029bernadette.johnson-williams@fda.hhs.gov

                                                                                  Content current as of:
      11/03/2023
         
                   
Regulated Product(s)
		 DrugsMore Meetings,
      Conferences, and
      Workshops
        
        News & Events

          
                        


                        FDA Meetings, Conferences and Workshops
          OTP Events, Meetings, and Workshops
          Rumor Control
          Approvals of FDA-Regulated Products
          Congressional Testimony
          FDA Newsroom
          Interactive and Social Media
          Public Health Focus
          Speeches by FDA Officials
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop